Page 135 - 2022_02-Haematologica-web

Endocrine complications in iron overload
transferrin bound iron levels and heart dis- ease in thalassemia major. Am J Hematol. 2009;84(1):29-33.
29. Wood JC, Glynos T, Thompson A, et al. Relationship between labile plasma iron, liver iron concentration and cardiac response in a deferasirox monotherapy trial. Haematologica 2011;96(7):1055-1058.
30. Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR, Thalassemia Clinical Research Network. complications of beta-thalassemia major in North America. Blood. 2004;104 (1):34-39.
31. Vogiatzi MG, Macklin EA, Trachtenberg FL, et al. Differences in the prevalence of growth, endocrine and vitamin D abnormal- ities among the various thalassaemia syn- dromes in North America. Br J Haematol. 2009;146(5):546-556.
32. Taher AT, Cappellini MD, Bou-Fakhredin R, Coriu D, Musallam KM. Hypercoagulability and vascular disease. Hematol Oncol Clin
North Am. 2018;32(2):237-245.
33.Pennell DJ, Udelson JE, Arai AE, et al.
Cardiovascular function and treatment in b- thalassemia major: a consensus statement from the American Heart Association. Circulation. 2013;128(13):281-308.
34. Salzano A, Marra AM, Arcopinto M, et al. Combined effects of growth hormone and testosterone replacement treatment in heart failure. ESC Heart Fail. 2019;6(6):1216-1221.
35. Rochira V. Late-onset hypogonadism: bone health. Andrology. 2020;8(6):1539-1550.
36. Feingold KR, Anawalt B, Boyce A, et al., edi-
tors. Endotext. South Dartmouth (MA): MDText.com, Inc., 2000 http://www.ncbi.nlm.nih.gov/books/NBK2 78943/ (accessed August 15, 2020).
37. Niknam N, Khalili N, Khosravi E, Nourbakhsh M. Endothelial dysfunction in patients with subclinical hypothyroidism and the effects of treatment with levothy- roxine. Adv Biomed Res. 2016;5:38.
38. Aggeli C, Antoniades C, Cosma C, et al. Endothelial dysfunction and inflammatory process in transfusion-dependent patients with beta-thalassemia major. Int J Cardiol. 2005;105(1):80-84.
39. Gursel O, Tapan S, Sertoglu E, et al. Elevated plasma asymmetric dimethylarginine levels in children with beta-thalassemia major may be an early marker for endothelial dys- function. Hematology. 2018;23(5):304-308.
40. Clerico A, Trenti T, Aloe R, et al. A multicen- ter study for the evaluation of the reference interval for TSH in Italy (ELAS TSH Italian Study). Clin Chem Lab Med. 2018;57(2): 259-267.
41. Bidlingmaier M, Strasburger CJ. Growth hormone assays: current methodologies and their limitations. Pituitary. 2007;10(2):115- 119.
42. Jameson JL, De Groot LJ. Endocrinology-E- Book: Adult and Pediatric. Elsevier Health Sciences, 2010.
haematologica | 2022; 107(2)
477